Imunorix®



Product description

Pidotimod is the first compound of a new class of modifiers of biological responses, with a peptide-like structure obtained by synthesis, which is well characterized and chemically pure. Furthermore, pidotimod shows a high oral bioavailability. 

The drug has proven to be active on the aspecific and the specific components of immune response.

 

Indication

Immuno-correcting therapy of bacterial, fungous and viral infection of upper and lower airways and urinary tracts, as part of complex therapy.

 

Product category

respiratory

Last update: September 16, 2015 at 03:03 PM



Access to certain product information is permitted to Members (registered users) only. Click the button to login or create your new user profile. 

Enter member area